Velban Side Effects
Generic Name: vinblastine
Note: This document contains side effect information about vinblastine. Some of the dosage forms listed on this page may not apply to the brand name Velban.
For the Consumer
Applies to vinblastine: intravenous solution
Along with their needed effects, medicines like vinblastine (the active ingredient contained in Velban) can sometimes cause unwanted effects such as blood problems, loss of hair, and other side effects. These and other effects are described below. Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.
Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking vinblastine:
- Cough or hoarseness accompanied by fever or chills
- fever or chills
- lower back or side pain accompanied by fever or chills
- painful or difficult urination accompanied by fever or chills
- Blood in urine or stools
- pain or redness at place of injection
- pinpoint red spots on skin
- unusual bleeding or bruising
- Black, tarry stools
Check with your doctor as soon as possible if any of the following side effects occur while taking vinblastine:
- Joint pain
- sores in mouth and on lips
- swelling of feet or lower legs
- Difficulty in walking
- double vision
- drooping eyelids
- jaw pain
- mental depression
- numbness or tingling in fingers and toes
- pain in fingers and toes
- pain in testicles
Some side effects of vinblastine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Bone or muscle pain
- nausea and vomiting
This medicine often causes a temporary loss of hair. After treatment with vinblastine has ended, or sometimes even during treatment, normal hair growth should return.
For Healthcare Professionals
Applies to vinblastine: intravenous powder for injection, intravenous solution
Very rare (less than 0.01%): Myocardial infarction, angina pectoris, transient abnormalities of ECG related to coronary ischemia
Frequency not reported: Hypertension, cerebrovascular accident/Raynaud's phenomenon (in patients undergoing combination chemotherapy with vinblastine (the active ingredient contained in Velban) bleomycin and cisplatin)[Ref]
Common (1% to 10%): Alopecia
Very rare (less than 0.01%): Light sensitivity
Frequency not reported: Acute shortness of breath, bronchospasm[Ref]
Frequency not reported: Constipation, anorexia, nausea, vomiting, abdominal pain, ileus, vesiculation of the mouth, pharyngitis, diarrhea, hemorrhagic enterocolitis, bleeding from an old peptic ulcer, rectal bleeding, stomatitis[Ref]
Frequency not reported: Syndrome of inappropriate antidiuretic hormone secretion (SIADH)[Ref]
Frequency not reported: Bone pain, jaw pain[Ref]
Rare (0.01% to 0.1%): Vestibular and auditory damage to the eighth cranial nerve (causing partial or total deafness which may be temporary or permanent)
Very rare (less than 0.01%):
Frequency not reported: Malaise, weakness, pain in the tumor-containing tissue[Ref]
Frequency not reported: Depression[Ref]
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. VinBLAStine Sulfate (vinBLAStine)." Fresenius Kabi USA, Lake Zurich, IL.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.